Go Pro
NASDAQ:SNWV

Sanuwave Health (SNWV) Stock Price, News & Analysis

Sanuwave Health logo
$4.57 +0.02 (+0.44%)
As of 11:01 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Sanuwave Health Stock (NASDAQ:SNWV)

Advanced

Key Stats

Today's Range
$4.30
$4.68
50-Day Range
$4.00
$11.96
52-Week Range
$3.92
$40.87
Volume
20,118 shs
Average Volume
118,231 shs
Market Capitalization
$39.30 million
P/E Ratio
19.04
Dividend Yield
N/A
Price Target
$47.00
Consensus Rating
Reduce

Company Overview

SANUWAVE Health, Inc. is a medical technology company focused on regenerative medicine and noninvasive treatments designed to support tissue repair and wound healing. The company’s activities center on developing and commercializing therapies for chronic and difficult-to-heal wounds.

SANUWAVE’s primary product is the dermaPACE System, which uses extracorporeal shock wave technology to deliver acoustic energy to targeted tissue. The system is intended to stimulate biological processes associated with healing and has been developed for applications including diabetic foot ulcers and other chronic wounds.

The company has pursued regulatory approvals and commercial opportunities in the United States and international markets. SANUWAVE is headquartered in Alpharetta, Georgia, and its business is primarily focused on advancing the clinical use and adoption of its regenerative medicine technologies.

AI Generated. May Contain Errors.

Sanuwave Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

SNWV MarketRank™: 

Sanuwave Health scored higher than 42% of companies evaluated by MarketBeat, and ranked 608th out of 895 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sanuwave Health has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 2 sell ratings.

  • Upside Potential

    Sanuwave Health has a consensus price target of $47.00, representing about 928.4% upside from its current price of $4.57.

  • Amount of Analyst Coverage

    Sanuwave Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Sanuwave Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sanuwave Health is 19.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.04.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sanuwave Health is 19.04, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.65.

  • Price to Book Value per Share Ratio

    Sanuwave Health has a P/B Ratio of 24.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Sanuwave Health's valuation and earnings.
  • Percentage of Shares Shorted

    3.96% of the float of Sanuwave Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Sanuwave Health has a short interest ratio ("days to cover") of 4.69.
  • Change versus previous month

    Short interest in Sanuwave Health has recently decreased by 4.33%, indicating that investor sentiment is improving.
  • Dividend Yield

    Sanuwave Health does not currently pay a dividend.

  • Dividend Growth

    Sanuwave Health does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Sanuwave Health this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for SNWV on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sanuwave Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.40% of the stock of Sanuwave Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.53% of the stock of Sanuwave Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sanuwave Health's insider trading history.
Receive SNWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanuwave Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNWV Stock News Headlines

SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from S&P Global BMI Index
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Sanuwave Announces Q2 FY2026 Financial Results
See More Headlines

SNWV Stock Analysis - Frequently Asked Questions

Sanuwave Health's stock was trading at $29.84 at the beginning of 2026. Since then, SNWV shares have decreased by 84.7% and is now trading at $4.57.

Sanuwave Health Inc. (NASDAQ:SNWV) issued its quarterly earnings results on Thursday, August, 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.05. The business earned $9.74 million during the quarter, compared to the consensus estimate of $11.50 million. Sanuwave Health had a net margin of 32.38% and a trailing twelve-month return on equity of 1,728.10%.
Read the conference call transcript
.

Sanuwave Health shares reverse split on Friday, October 18th 2024.The 1-375 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Sanuwave Health's top institutional shareholders include Solas Capital Management LLC (7.11%), AWM Investment Company Inc. (5.29%), Opaleye Management Inc. (3.56%) and BlackRock Inc. (1.86%). Insiders that own company stock include Peter Stegagno and Iulian Cioanta.
View institutional ownership trends
.

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sanuwave Health investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
8/06/2026
Today
9/21/2026
Next Earnings (Estimated)
11/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:SNWV
Previous Symbol
NASDAQ:SNWV
CIK
1417663
Employees
55
Year Founded
2005

Price Target and Rating

High Price Target
$47.00
Low Price Target
$47.00
Potential Upside/Downside
+928.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.24
Trailing P/E Ratio
19.04
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.81 million
Net Margins
32.38%
Pretax Margin
34.73%
Return on Equity
1,728.10%
Return on Assets
39.04%

Debt

Debt-to-Equity Ratio
4.87
Current Ratio
1.28
Quick Ratio
0.89

Sales & Book Value

Annual Sales
$44.02 million
Price / Sales
0.89
Cash Flow
$1.71 per share
Price / Cash Flow
2.68
Book Value
$0.19 per share
Price / Book
24.05

Miscellaneous

Outstanding Shares
8,599,000
Free Float
7,361,000
Market Cap
$39.30 million
Optionable
N/A
Beta
1.47

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:SNWV) was last updated on 9/21/2026 by MarketBeat.com Staff.
From Our Partners